Caribou Biosciences stockholders approve reverse stock split authorization at annual meeting

Caribou Biosciences, Inc.

Class I directors elected: Scott Braunstein (40.2M votes for) and Ran Zheng (30.4M votes for).
Deloitte & Touche ratified as independent auditor for FY2025 (66.5M for, 1.1M against).
Amendment to charter approved to allow reverse stock split at ratio from 1:5 to 1:50, as determined by board.
Adjournment proposal approved but unnecessary due to quorum and sufficient votes on all proposals.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.